Literature DB >> 21521685

HSP70 protein promotes survival of C6 and U87 glioma cells by inhibition of ATF5 degradation.

Guangfu Li1, Yidi Xu, Dongyin Guan, Zhengshan Liu, David X Liu.   

Abstract

Although both the heat shock protein 70 (HSP70) and the activating transcription factor 5 (ATF5) have been shown to promote cell survival of transformed cells but not survival of non-transformed cells, the relationship of the two molecules is unknown. Here we show that HSP70 and ATF5 are concomitantly up-regulated upon transient but down-regulated over prolonged cellular stress and apoptotic stimulation in the rat C6 glioma and human U87 glioma cells. HSP70 interacts strongly with the N-terminal activation domain of ATF5, which is expected to be rigid and uniquely structured under physiological conditions because of extraordinary high concentration (over 25%) of proline residues. Binding of HSP70 to ATF5 is an ATP-driven process and requires functional ATPase on the nucleotide binding domain of the HSP70 molecule. Overexpression of HSP70 dramatically stabilizes the ATF5 protein, which is otherwise subject to rapid degradation, facilitated by both proteasome-dependent and caspase-dependent processes, whereas HSP70 depletion leads to acceleration of ATF5 degradation and transcription repression of Bcl-2 and Egr-1, which are downstream targets of ATF5 in C6 and U87 glioma cells. Our data reveal an essential role for HSP70 in maintaining high levels of ATF5 expression in glioma cells and support the conclusion that ATF5 is an important substrate protein of HSP70 that mediates HSP70-promoted cell survival in glioma cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521685      PMCID: PMC3121475          DOI: 10.1074/jbc.M110.211771

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Amino acid limitation induces expression of ATF5 mRNA at the post-transcriptional level.

Authors:  Yujiro Watatani; Natsumi Kimura; Yusuke I Shimizu; Itsuka Akiyama; Daijuro Tonaki; Hidenori Hirose; Shigeru Takahashi; Yuji Takahashi
Journal:  Life Sci       Date:  2006-11-11       Impact factor: 5.037

2.  Clonogenic assay of cells in vitro.

Authors:  Nicolaas A P Franken; Hans M Rodermond; Jan Stap; Jaap Haveman; Chris van Bree
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5.

Authors:  J M Angelastro; P D Canoll; J Kuo; M Weicker; A Costa; J N Bruce; L A Greene
Journal:  Oncogene       Date:  2006-02-09       Impact factor: 9.867

4.  Hsp70 protects against UVB induced apoptosis by preventing release of cathepsins and cytochrome c in human melanocytes.

Authors:  Cecilia Bivik; Inger Rosdahl; Karin Ollinger
Journal:  Carcinogenesis       Date:  2006-08-31       Impact factor: 4.944

5.  The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines.

Authors:  Sara E Monaco; James M Angelastro; Matthias Szabolcs; Lloyd A Greene
Journal:  Int J Cancer       Date:  2007-05-01       Impact factor: 7.396

Review 6.  Heat shock proteins as cellular lifeguards.

Authors:  M Jäättelä
Journal:  Ann Med       Date:  1999-08       Impact factor: 4.709

Review 7.  Therapeutic advances for glioblastoma multiforme: current status and future prospects.

Authors:  H Ian Robins; Susan Chang; Nicholas Butowski; Minesh Mehta
Journal:  Curr Oncol Rep       Date:  2007-01       Impact factor: 5.075

8.  Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms.

Authors:  Mikkel Rohde; Mads Daugaard; Mette Hartvig Jensen; Kristian Helin; Jesper Nylandsted; Marja Jäättelä
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

Review 9.  Heat shock proteins in cancer: chaperones of tumorigenesis.

Authors:  Stuart K Calderwood; Md Abdul Khaleque; Douglas B Sawyer; Daniel R Ciocca
Journal:  Trends Biochem Sci       Date:  2006-02-17       Impact factor: 13.807

Review 10.  Changing paradigms--an update on the multidisciplinary management of malignant glioma.

Authors:  Roger Stupp; Monika E Hegi; Martin J van den Bent; Warren P Mason; Michael Weller; René O Mirimanoff; J Gregory Cairncross
Journal:  Oncologist       Date:  2006-02
View more
  34 in total

1.  Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy.

Authors:  Courtney A Crane; Brian J Ahn; Seunggu J Han; Andrew T Parsa
Journal:  Neuro Oncol       Date:  2012-03-09       Impact factor: 12.300

2.  Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells.

Authors:  Gisela Natalia Castro; Niubys Cayado-Gutiérrez; Felipe Carlos Martín Zoppino; Mariel Andrea Fanelli; Fernando Darío Cuello-Carrión; Mayra Sottile; Silvina Beatriz Nadin; Daniel Ramón Ciocca
Journal:  Cell Stress Chaperones       Date:  2014-08-26       Impact factor: 3.667

Review 3.  Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma.

Authors:  Georg Karpel-Massler; Chiaki Tsuge Ishida; Yiru Zhang; Marc-Eric Halatsch; M-Andrew Westhoff; Markus D Siegelin
Journal:  Expert Opin Drug Discov       Date:  2017-07-20       Impact factor: 6.098

Review 4.  Mitochondrial dysfunction in cancer: Potential roles of ATF5 and the mitochondrial UPR.

Authors:  Pan Deng; Cole M Haynes
Journal:  Semin Cancer Biol       Date:  2017-05-10       Impact factor: 15.707

5.  miR-141-3p functions as a tumor suppressor modulating activating transcription factor 5 in glioma.

Authors:  Mengyuan Wang; Ming Hu; Zhaohua Li; Dongmeng Qian; Bin Wang; David X Liu
Journal:  Biochem Biophys Res Commun       Date:  2017-06-07       Impact factor: 3.575

6.  Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas.

Authors:  Eugenio Gaudio; Francesco Paduano; Apollinaire Ngankeu; Francesca Lovat; Muller Fabbri; Hui-Lung Sun; Pierluigi Gasparini; Alexey Efanov; Yong Peng; Nicola Zanesi; Mohammed A Shuaib; Laura Z Rassenti; Thomas J Kipps; Chenglong Li; Rami I Aqeilan; Gregory B Lesinski; Francesco Trapasso; Carlo M Croce
Journal:  Blood       Date:  2012-11-15       Impact factor: 22.113

7.  SUMO2/3 modification of activating transcription factor 5 (ATF5) controls its dynamic translocation at the centrosome.

Authors:  Yunsheng Yuan; Kari Gaither; Eugene Kim; Edward Liu; Ming Hu; Kathy Lengel; Dongmeng Qian; Yidi Xu; Bin Wang; Henning Knipprath; David X Liu
Journal:  J Biol Chem       Date:  2018-01-11       Impact factor: 5.157

8.  A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers.

Authors:  Georg Karpel-Massler; Basil A Horst; Chang Shu; Lily Chau; Takashi Tsujiuchi; Jeffrey N Bruce; Peter Canoll; Lloyd A Greene; James M Angelastro; Markus D Siegelin
Journal:  Clin Cancer Res       Date:  2016-04-28       Impact factor: 12.531

9.  Phase I study of BIIB028, a selective heat shock protein 90 inhibitor, in patients with refractory metastatic or locally advanced solid tumors.

Authors:  David Hong; Rabih Said; Gerald Falchook; Aung Naing; Stacy Moulder; Apostolia-Maria Tsimberidou; Gerald Galluppi; Naveen Dakappagari; Chris Storgard; Razelle Kurzrock; Lee S Rosen
Journal:  Clin Cancer Res       Date:  2013-07-19       Impact factor: 12.531

10.  The human secretome atlas initiative: implications in health and disease conditions.

Authors:  Kristy J Brown; Haeri Seol; Dinesh K Pillai; Binu-John Sankoorikal; Catherine A Formolo; Jenny Mac; Nathan J Edwards; Mary C Rose; Yetrib Hathout
Journal:  Biochim Biophys Acta       Date:  2013-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.